Literature DB >> 23577654

Assessment of cognitive function in adult patients with hemorrhagic moyamoya disease who received no surgical revascularization.

S-H Su1, J Hai, L Zhang, F Yu, Y-F Wu.   

Abstract

BACKGROUND AND
PURPOSE: Due to controversial surgical treatment for hemorrhagic moyamoya disease (MMD), a large proportion of these patients chose conservative treatment. The aim of this study was to assess cognitive function in adult patients with hemorrhagic MMD who received no surgical revascularization.
METHODS: Twenty-six adult hemorrhagic MMD patients with only intraventricular hemorrhage (IVH) confirmed by positive computed tomography and magnetic resonance imaging scan, 20 patients with spontaneous IVH whose digital subtraction angiography results were negative, and 30 healthy controls were identified and matched for age, gender, education background and living area. Cognitive function was evaluated by Montreal Cognitive Assessment (MoCA). The non-parametric test was used for comparisons among the three groups.
RESULTS: No patient was confirmed cognitive dysfunction at the initial screening. Twenty-four (92%) cases presented mild cognitive impairment (MCI) after 1 year. All the cases demonstrated MCI after 2 years. The difference between cases and healthy controls was statistically significant at the second screening (P = 0.000) and the third screening (P = 0.000), as was that between cases and patients with spontaneous IVH at the second screening (P = 0.000) and the third screening (P = 0.000). In addition, there were significant decreases in all MoCA subscores (P = 0.000) with special regards to delayed recall, visual space and executive function in cases compared with the other two groups. Moreover, significant differences were found in the subgroups of smoking (P = 0.021) and Suzuki angiographic classification of MMD (P = 0.030).
CONCLUSIONS: Cognitive impairment is a long-term complication for adult hemorrhagic MMD patients who underwent conservative treatment.
© 2013 The Author(s) European Journal of Neurology © 2013 EFNS.

Entities:  

Mesh:

Year:  2013        PMID: 23577654     DOI: 10.1111/ene.12138

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  9 in total

1.  Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 ameliorate neuroinflammatory responses in chronic cerebral hypoperfusion model by blocking NF-κB pathways.

Authors:  Shao-Hua Su; Yi-Fang Wu; Qi Lin; Jian Hai
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-08-19       Impact factor: 3.000

2.  Changes in Brain Functional Network Connectivity in Adult Moyamoya Diseases.

Authors:  Gaoxing Zheng; Yu Lei; Yuzhu Li; Wei Zhang; Jiabin Su; Xiaoying Qi; Liang Chen; Xin Zhang; Yuxiang Gu; Yuguo Yu; Ying Mao
Journal:  Cogn Neurodyn       Date:  2021-02-07       Impact factor: 3.473

3.  Cognitive Performance Profile in Pediatric Moyamoya Disease Patients and Its Relationship With Regional Cerebral Blood Perfusion.

Authors:  Jiaxi Li; Xingju Liu; Dong Zhang; Yan Zhang; Rong Wang; Jing Yuan; Jizong Zhao
Journal:  Front Neurol       Date:  2019-12-12       Impact factor: 4.003

4.  Faded Critical Dynamics in Adult Moyamoya Disease Revealed by EEG and fMRI.

Authors:  Yu Lei; Yuzhu Li; Lianchun Yu; Longzhou Xu; Xin Zhang; Gaoxing Zheng; Liang Chen; Wei Zhang; Xiaoying Qi; Yuxiang Gu; Yuguo Yu; Ying Mao
Journal:  Oxid Med Cell Longev       Date:  2021-04-16       Impact factor: 6.543

5.  Predictors of preoperative cognitive dysfunction in adults with Moyamoya disease: a preliminary research.

Authors:  Jian Sun; Zhiyong Shi; Lebao Yu; Yujie Wen; Dong Zhang
Journal:  BMC Neurol       Date:  2022-01-06       Impact factor: 2.474

6.  Cognitive Functions in Children and Adults with Moyamoya Vasculopathy: A Systematic Review and Meta-Analysis.

Authors:  Annick Kronenburg; Esther van den Berg; Monique M van Schooneveld; Kees P J Braun; Lionel Calviere; Albert van der Zwan; Catharina J M Klijn
Journal:  J Stroke       Date:  2018-09-30       Impact factor: 6.967

7.  Inhibition of excessive autophagy and mitophagy mediates neuroprotective effects of URB597 against chronic cerebral hypoperfusion.

Authors:  Shao-Hua Su; Yi-Fang Wu; Da-Peng Wang; Jian Hai
Journal:  Cell Death Dis       Date:  2018-06-28       Impact factor: 8.469

8.  A nomogram to predict cognitive impairment after supratentorial spontaneous intracranial hematoma in adult patients: A retrospective cohort study.

Authors:  Kai Gong; Lizheng Zhao; Jianfeng Guo; Zhanxiang Wang
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

9.  Different aspects of cognitive function in adult patients with moyamoya disease and its clinical subtypes.

Authors:  Zhiyong Shi; Yu-Jie Wen; Zheng Huang; Le-Bao Yu; Dong Zhang
Journal:  Stroke Vasc Neurol       Date:  2020-03-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.